Waters Corporation(WAT)Earnings, Financials & Key RatiosWaters Corporation (WAT) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's inability to maintain positive free cash flow, which hit -3.3% in 2026Q1, combined with significant goodwill concentration, suggests that the current 34.80 P/E valuation may not be justified.
Waters Corporation (WAT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Waters Corporation (WAT) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 5, 2026 | $2.70vs $2.31+16.9% | $1.3Bvs $1.2B+5.3% |
| Q1 2026 | Feb 9, 2026 | $4.53vs $4.51+0.4% | $932Mvs $928M+0.4% |
| Q4 2025 | Nov 4, 2025 | $3.40vs $3.21+5.9% | $800Mvs $781M+2.4% |
| Q3 2025 | Aug 4, 2025 | $2.95vs $2.94+0.3% | $771Mvs $749M+3.0% |
Recent stock market news and headlines for Waters Corporation (WAT)
MILFORD, Mass., July 2, 2026 /PRNewswire/ -- Waters Corporation (NYSE: WAT) will hold its Q2 2026 financial results conference call on Tuesday, August 4, 2026, at 8:00 a.m.
LONDON--(BUSINESS WIRE)--IMU Biosciences, a biotechnology company decoding the immune system to pioneer a paradigm shift in how we understand, diagnose, and treat disease, and Waters Corporation (NYSE: WAT) today announced a strategic partnership to accelerate the development of IMU's next-generation AI-powered High Definition (HD) Immunology platform.The partnership brings together Waters Biosciences' advanced flow cytometry and single-cell technologies,1 including BD FACSDiscover Cell Analyzer.
Key metrics vs top competitors for Waters Corporation (WAT)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $374.93 | $24.44B | 34.84 | 6.99% | 20.3% | 29.28% | — | |
| $131.14 | $37.04B | 28.70 | 6.73% | 19.55% | 20.84% | — | |
| $58.25 | $8.87B | -388.33 | 2.08% | -0.34% | -0.5% | — | |
| $304.82 | $23.26B | -417.56 | 32.58% | 16.46% | 13.19% | — | |
| $3.73 | $136.88M | -5.04 | 2.63% | -4.44% | — | — | |
| $516.62 | $191.99B | 29.12 | 3.91% | 15.18% | 13.23% | — |
Waters Corporation (WAT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Waters Corporation (WAT) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 5, 2026·SEC
Mar 23, 2026·SEC
Mar 16, 2026·SEC
Get notified when WAT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Waters Corporation (WAT) stock FAQ — growth, dividends, profitability & financials explained
Waters Corporation (WAT) reported $3.77B in revenue for fiscal year 2025. This represents a 864% increase from $391.1M in 1996.
Waters Corporation (WAT) grew revenue by 7.0% over the past year. This is steady growth.
Yes, Waters Corporation (WAT) is profitable, generating $449.2M in net income for fiscal year 2025 (20.3% net margin).
Waters Corporation (WAT) has a return on equity (ROE) of 29.3%. This is excellent, indicating efficient use of shareholder capital.
Waters Corporation (WAT) generated $264.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.
